In this week’s briefing:
Therapsil Applies Cannabis Legalization Strategy to Psilocybin Efforts

'Decriminalize Nature' Movement Growing Nationwide

Clearmind Seeks to Secure FDA Approval With New Board Member

World’s First Non-Profit Psychedelics Research Institute 

Phase 2 Ketamine Clinical Study is a Go for PharmaTher

In this week’s briefing: Therapsil Applies Cannabis Legalization Strategy to Psilocybin Efforts 'Decriminalize Nature' Movement Growing Nationwide Clearmind Seeks to Secure FDA Approval With New Board Member World’s First Non-Profit Psychedelics Research Institute Phase 2 Ketamine Clinical Study is a Go for PharmaTher

In this week’s briefing:
Therapsil Applies Cannabis Legalization Strategy to Psilocybin Efforts

'Decriminalize Nature' Movement Growing Nationwide

Clearmind Seeks to Secure FDA Approval With New Board Member

World’s First Non-Profit Psychedelics Research Institute&nbsp;

Phase 2 Ketamine Clinical Study is a Go for PharmaTher

The Briefing, August 9: New Framework For Psychedelics?

Report on Psychedelics is the leading source of independent data and intelligence for the emerging psychedelics industry.

Share The Briefing, August 9: New Framework For Psychedelics?

Sign up to save your podcasts

The Briefing, August 9: New Framework For Psychedelics?

The Briefing, August 9: New Framework For Psychedelics?